Decline in Community Pharmacy Availability in deprived Areas of England

Research shows that community pharmacy availability in England is decreasing, especially in economically deprived areas, risking increased health inequalities and reduced access to vital healthcare services.
Recent research highlights a concerning decline in the availability of community pharmacies across England, particularly impacting deprived areas with poorer health outcomes. A study conducted by researchers from Newcastle University, the University of Manchester, and Health Equity North analyzed data from 2014 to 2023 and found that while over 90% of the population lives within a 20-minute walk to a pharmacy, the overall number of pharmacies has decreased from 1.6 to 1.5 per 10,000 people. Notably, the most deprived regions experienced a 65% higher likelihood of losing their local pharmacy compared to wealthier areas.
Pharmacies are vital components of the healthcare system, offering accessible services such as smoking cessation programs, contraceptive support, hypertension screening, and flu vaccinations. Despite their importance, recent funding cuts and closures have led to increased health inequalities. The study revisited the 'positive pharmacy care law,' which suggests that deprived communities should have better access to local pharmacies. Although this law remains valid, its influence has lessened over time, and access is shrinking especially in the most vulnerable areas.
Numerical analysis revealed that in 2014, deprived areas had 2.28 pharmacies per 10,000 people, which declined to 2.01 in 2023. Conversely, the least deprived areas saw a reduction from 1.37 to 1.33 per 10,000 people. The decline was most significant in urban regions, with an 8.2% decrease in pharmacy availability. These trends mean more residents in disadvantaged communities will rely on fewer pharmacies, limiting access to essential clinical services.
Experts warn that ongoing funding reductions threaten the capacity of community pharmacies to deliver extended healthcare services, which may lead to further health disparities. Reinvestment in pharmacy networks is vital to address current challenges and support the delivery of public health initiatives in underserved areas.
As lead author Eman Zied Abozied emphasized, without adequate funding and strategic support, the strain on pharmacies serving high-need communities could intensify, potentially widening existing health inequalities. Health authorities are urged to consider increased investment to sustain pharmacy services and improve healthcare equity across England.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Key Mechanism Identified That Shields SARS-CoV-2 During Replication
Researchers have identified a vital mechanism that SARS-CoV-2 uses to protect its spike protein during replication, offering new targets for antiviral therapies and vaccine development.
Promising Early-Stage HIV Vaccine Shows Targeted Immune Response in Human Trial
Amsterdam researchers have developed an innovative HIV vaccine that successfully triggers targeted immune responses in early trials, marking a significant step toward an effective global HIV vaccine.
New Study Reveals Vepdegestrant Extends Survival in Patients with Advanced ER+ Breast Cancer Featuring ESR1 Mutations
A new clinical trial reveals that vepdegestrant significantly improves progression-free survival in patients with ER-positive, HER2-negative advanced breast cancer with ESR1 mutations. Learn about the latest advancements in targeted breast cancer therapy.